In the high-stakes world of pharmaceutical manufacturing, patient safety is more than a regulatory requirement; it is the bedrock of industry trust. As clinical data matures and post-marketing surveillance unearths new evidence, global regulators are increasingly tightening the leash on Fixed Dose Combinations (FDCs).

16 FDCs Prohibited in India: Partner with Walter Healthcare for Compliance

This June 2026 notification signals a maturing pharmacovigilance framework. For stakeholders from large-scale manufacturers and CMOs to frontline healthcare providers, the message is clear: scientific justification is the only path to market survival. This article breaks down the ban and explores the strategic shifts necessary for industry compliance.

Akshay Gautam

Jun 2712 min read

In the high-stakes arena of global pharmaceuticals, the path from molecule to market is governed by an intricate web of scientific rigors and regulatory expectations. While clinical efficacy is the primary objective, pharmacopoeial compliance serves as the foundational bedrock of quality. At Walter Healthcare, we view these standards not as bureaucratic hurdles, but as the universal language of pharmaceutical trust.

Walter Healthcare at the Forefront of Global Pharmacopoeial Excellence

The acronyms USP, IP, BP, JP, and EP are more than mere technical markers; they are seals of scientific integrity. These pharmacopoeias provide the rigorous analytical frameworks that ensure every Active Pharmaceutical Ingredient (API) and finished dosage form possesses the identity, purity, and potency required to deliver its intended therapeutic outcome safely and predictably. For the modern pharmaceutical executive, mastery of these standards is a core component of market

Akshay Gautam

Jun 138 min read

The pharmaceutical sector operates at the most critical ethical juncture in the global economy. It is the domain where the abstract potential of science is forged directly into the tangible reality of human health and longevity. Every capsule, every vial, every therapeutic agent is not merely a product on a shelf; it is a profound commitment, a solemn covenant with the patient that it is safe, effective, and will deliver reliably at the most critical moments of life.

Walter Healthcare Building Trust in Pharmaceutical Manufacturing Through Regulatory Excellence

This vital commitment is maintained by a strong, globally consistent system of strict monitoring, high standards, and clear accountability. This system of excellent regulation is the foundation for companies like Walter Healthcare. While some might see regulation as a complicated bureaucracy that slows things down, responsible drug manufacturers recognize it as the necessary protection. It is the crucial element that safeguards patient health and the trustworthiness of life-s

Akshay Gautam

Apr 1110 min read

Capsules are a cornerstone of pharmaceutical and nutraceutical delivery, ranking as one of the world's most popular oral dosage forms. Their widespread adoption is due to superior benefits such as ease of use, accurate dosing, inherent versatility, and excellent protection for active ingredients. They offer a clean, convenient, and universally patient-friendly alternative to messy liquids or hard-to-swallow tablets.

Walter Healthcare Guide to Pharmaceutical Capsules

The formulation science behind capsules is dynamic, continually evolving in materials, structural designs, and specialized functionalities. This evolution allows them to meet specific therapeutic goals, from improving compound stability to dramatically enhancing absorption. Capsules are therefore indispensable in shaping the future of medicine and wellness products. At Walter Healthcare, we view a capsule as a sophisticated, precise delivery system, committed to exceptional q

Akshay Gautam

Mar 2112 min read

The global healthcare landscape is being fundamentally shaped by the rise of India’s pharmaceutical industry. No longer just a regional player, India has firmly established itself as a pivotal force in ensuring access to medicine worldwide. Impressive figures underscore this influence. India’s pharmaceutical exports soared past USD 30 billion in the fiscal year 2024-25, a substantial jump from USD 22 billion in FY 2020-21. This sustained growth, achieving a strong Compound Annual Growth Rate (CAGR) of over 9%, is a testament to the world’s increasing trust in Indian-manufactured generics, vaccines, Active Pharmaceutical Ingredients (APIs), and complex formulations, all built on a foundation of consistent quality and cost efficiency.

Indian Pharmaceuticals Excelling Beyond Border

The blog is an insight into India's pharmaceutical expertise as global player in the industry. The global healthcare landscape is being fundamentally shaped by the rise of India’s pharmaceutical industry. No longer just a regional player, India has firmly established itself as a pivotal force in ensuring access to medicine worldwide. Impressive figures underscore this influence. India’s pharmaceutical exports soared past USD 30 billion in the fiscal year 2024-25.

Akshay Gautam

Dec 31, 20258 min read

Pharma News & Blog